| abstract |
The invention relates to the use of porphyrin synthesis substances, in particular 5-amonolevulinic acid, if necessary in combination with salicylates in the form of acetylsalicyc acid and with antioxydising agents in the form of ascorbic acid when a phototherapy is carried out with a light emission whose wavelength ranges from 400 to 700 nm pour treating inflammatory processes, for instance on the skin and/or articulations of mammalians and human beings, in particular for curing arthritis, simple psoriasis, arthopathic psoriasis and neuropathies such as a carpal tunnel syndrome or Bechterev's disease. |